📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma. (2020)

First Author: Sriskandarajah P

Attributed to: UoEdinburgh Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-020-06735-2

PubMed Identifier: 32228485

Publication URI: http://europepmc.org/abstract/MED/32228485

Type: Journal Article/Review

Volume: 20

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407